|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 38/57 | (2006.01) |
| A61P 5/00 | (2006.01) | ||
| A61K 47/02 | (2006.01) | ||
| A61K 47/18 | (2017.01) | ||
| A61K 47/12 | (2006.01) | ||
| A61K 9/00 | (2006.01) | ||
| A61K 9/08 | (2006.01) |
| (11) | Number of the document | 3290046 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17177676.8 |
| Date of filing the European patent application | 2014-03-17 | |
| (97) | Date of publication of the European application | 2018-03-07 |
| (45) | Date of publication and mention of the grant of the patent | 2019-01-02 |
| (46) | Date of publication of the claims translation | 2019-03-12 |
| (30) | Number | Date | Country code |
| 201361791399 P | 2013-03-15 | US |
| (72) |
GALLAGHER, Cynthia, US
RUDDY, Stephen, US
MANNING, Mark Cornell, US
|
| (73) |
ViroPharma Biologics LLC ,
300 Shire Way, Lexington, MA 02421,
US
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | C1-INH kompozicijos ir sutrikimų, susijusių su C1 esterazės inhibitoriaus nepakankamumu, prevencijos bei gydymo būdai |
| C1-INH COMPOSITIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF DISORDERS ASSOCIATED WITH C1 ESTERASE INHIBITOR DEFICENCY |
| Payment date | Validity (years) | Amount | |
| 2026-02-19 | 13 | 289.00 EUR |
| 2027-03-17 |